The Multicenter Prospective Randomized Controlled Trial Evaluating Efficacy of Ganglionic plexi (GP) Ablation in the Surgery for Atrial Fibrillation: Japan GP Ablation trial

JRCT ID: jRCT1032180079

Registered date:11/01/2019

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: Patients undergoing cardiac surgery
• Date of first enrollment: 01/05/2014
• Target sample size: 300
• Study type: Interventional
• Intervention(s): Maneuver (Standardization of atrial fibrillation procedure, Standerdization of GP mapping and ablation technique)s

Outcome(s)

• Primary Outcome: Recurrence of atrial tachycardia and atrial fibrillation in 2 years.
• Secondary Outcome: Recurrence of atrial tachycardia and atrial fibrillation, motality, and major adverse cardiac events in 6 months or 1 year.

Key inclusion & exclusion criteria

• Age minimum: 20age
• Age maximum: 80age
• Gender: Both
• Include criteria: Patients who have indication of atrial fibrillation surgery in the guidelines for non-pharmacotherapy of Cardiac Arrhythmias

Exclude criteria

1) Low cardiac function (EF<40%)
2) History of RFCA
3) Use of catechoramine
4) Thrombus in left atrial appendage
5) Pacemaker implantation
6) Non consent

Related Information

• Primary Sponsor: Ozawa Naomi